Patient Survival With and Without Radiation Therapy for Early-Stage Diffuse Large B-Cell Lymphoma in the Era of PET and Rituximab.

McLaughlin, Christopher; Ricco, Anthony; Singh, Raj; Mukhopadhyay, Nitai; Skoro, Nevena; Girma, Selamawit; Deng, Xiaoyan; Song, Shiyu

McLaughlin, Christopher; Ricco, Anthony; Singh, Raj; Mukhopadhyay, Nitai; Skoro, Nevena; Girma, Selamawit; Deng, Xiaoyan; Song, Shiyu.

Afiliação

McLaughlin C; Department of Radiation Oncology, University of Virginia, Charlottesville, Virginia.
Ricco A; Department of Radiation, Cancer Informatics Core, Virginia Commonwealth University Health, Richmond, Virginia.
Singh R; Department of Radiation, Cancer Informatics Core, Virginia Commonwealth University Health, Richmond, Virginia.
Mukhopadhyay N; Department of Biostatistics, Cancer Informatics Core, Virginia Commonwealth University Health, Richmond, Virginia.
Skoro N; Massey Cancer Center, Cancer Informatics Core, Virginia Commonwealth University Health, Richmond, Virginia.
Girma S; Massey Cancer Center, Cancer Informatics Core, Virginia Commonwealth University Health, Richmond, Virginia.
Deng X; Department of Biostatistics, Cancer Informatics Core, Virginia Commonwealth University Health, Richmond, Virginia.
Song S; Department of Radiation, Cancer Informatics Core, Virginia Commonwealth University Health, Richmond, Virginia.

Adv Radiat Oncol ; 7(4): 100930, 2022.

Article em En | MEDLINE | ID: mdl-35814857

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article